Trade Name(generic name): ['Actemra (tocilizumab)']
Spnosor: Various
Trial Phase: Phase 3
Institution: Roche
Trade Name(generic name): ['Bucillamine']
Spnosor: Revive Therapeutics Ltd.
Trial Phase: Phase 3
Institution: Revive Therapeutics Ltd.
Trade Name(generic name): ['Bamlanivimab (LY-CoV555)']
Spnosor: Lilly, Operation Warp Speed
Trial Phase: Phase 2/3
Institution: Lilly, AbCellera
Trade Name(generic name): ['VIR-7831 (GSK4182136)']
Spnosor: Vir Biotechnology, Inc.
Trial Phase: Phase 2/3
Institution: Vir Biotechnology, Inc., GSK
Trade Name(generic name): ['Mavrilimumab']
Spnosor: The Cleveland Clinic
Trial Phase: Phase 2
Institution: Kiniksa Pharmaceuticals
Trade Name(generic name): ['Casirivimab/imdevimab (REGN-COV2)']
Spnosor: Regeneron
Trial Phase: Phase 1/2/3
Institution: Regeneron
Trade Name(generic name): ['Galidesivir']
Spnosor: NIAID
Trial Phase: Phase 1b
Institution: BioCryst Pharmaceuticals
Trade Name(generic name): ['Heparin (UF and LMW)']
Spnosor: Operation Warp Speed, University of Pittsburgh
Trial Phase: Phase 2/3/4
Institution: NHLBI
Trade Name(generic name): ['CT-P59']
Spnosor: Celltrion
Trial Phase: Phase 3
Institution: Celltrion
Trade Name(generic name): ['Veklury (remdesivir)']
Spnosor: Gilead Sciences
Trial Phase: Phase 2/3
Institution: Gilead Sciences
Trade Name(generic name): ['Avigan (favilavir/avifavir)']
Spnosor: Various
Trial Phase: Phase 2/3
Institution: Fujifilm Toyama Chemical (as Avigan), Zhejiang Hisun Pharmaceutical
Trade Name(generic name): ['PRO 140 (leronlimab)']
Spnosor: CytoDyn
Trial Phase: Phase 2b/3
Institution: CytoDyn
Trade Name(generic name): ['Olumiant, Baricinix (baricitinib)']
Spnosor: Eli Lilly, NIAID
Trial Phase: Phase 3/4
Institution: Eli Lilly
Trade Name(generic name): ['INOpulse']
Spnosor: Bellerophon Therapeutics
Trial Phase: Phase 3
Institution: Bellerophon Therapeutics
Trade Name(generic name): ['Ivermectin']
Spnosor: Various
Trial Phase: Phase 2/3
Institution: Various
Trade Name(generic name): ['Metformin (Glucophage, Glumetza, Riomet)']
Spnosor: University of Minnesota
Trial Phase: Phase 2/3
Institution: University of Minnesota
Trade Name(generic name): ['MK-4482']
Spnosor: Ridgeback Biotherapeutics
Trial Phase: Phase 2
Institution: DRIVE, Ridgeback Biotherapeutics, Merck
Trade Name(generic name): ['AZD7442']
Spnosor: AstraZeneca, BARDA
Trial Phase: Phase 3
Institution: AstraZeneca, Vanderbilt University Medical Center
Trade Name(generic name): ['Kaletra (lopinavir-ritonavir)']
Spnosor: Various
Trial Phase: Phase 2/4
Institution: AbbVie
Trade Name(generic name): ['Dexamethasone (Dextenza, Ozurdex, others)']
Spnosor: University of Oxford
Trial Phase: Phase 2/3
Institution: Various
Trade Name(generic name): ['Colchicine (Mitigare, Colcrys)']
Spnosor: Montreal Heart Institute
Trial Phase: Phase 2/3
Institution: NHLBI, Bill and Melinda Gates Foundation, Government of Quebec
Trade Name(generic name): ['PTC299']
Spnosor: PTC
Trial Phase: Phase 2/3
Institution: PTC
Trade Name(generic name): ['Lenzilumab']
Spnosor: NIAID
Trial Phase: Phase 3
Institution: Humanigen, Catalent
Trade Name(generic name): ['RLF-100 (aviptadil)']
Spnosor: NeuroRx
Trial Phase: Phase 2/3
Institution: NeuroRx, Relief Therapeutics
Trade Name(generic name): ['AT-527']
Spnosor: Atea Pharmaceuticals, Inc.
Trial Phase: Phase 2
Institution: Atea Pharmaceuticals, Inc.
Trade Name(generic name): ['Niclocide (niclosamide)']
Spnosor: Tufts Medical Center, First Wave Bio, Inc., Lille University Hospital
Trial Phase: Phase 2/3
Institution: ANA Therapeutics
Trade Name(generic name): ['Convalescent plasma']
Spnosor: Various
Trial Phase: Phase 1/2
Institution: Various
Trade Name(generic name): ['Pepcid (famotidine)']
Spnosor: Northwell Health
Trial Phase: Phase 3
Institution: Yamanouchi Pharmaceutical Co., J&J, Merck
Trade Name(generic name): ['Remicade (infliximab)']
Spnosor: UHB, Birmingham National Institute for Health Research Biomedical Research Centre (NIHR BRC), NCATS, BARDA
Trial Phase: Phase 2/3
Institution: Janssen
Trade Name(generic name): ['STI-5656 (abivertinib)']
Spnosor: Sorrento Therapeutics
Trial Phase: Phase 2
Institution: Sorrento Therapeutics
Trade Name(generic name): ['JS016']
Spnosor: Lilly
Trial Phase: Phase 1
Institution: Lilly, Junshi Biosciences
Trade Name(generic name): ['Kevzara (sarilumab)']
Spnosor: Sanofi, Regeneron
Trial Phase: No longer being studied for COVID-19
Institution: Sanofi, Regeneron
Trade Name(generic name): ['SACCOVID (CD24Fc)']
Spnosor: OncoImmune
Trial Phase: Phase 3
Institution: OncoImmune
Trade Name(generic name): ['Humira (adalimumab)']
Spnosor: COVID-19 Therapeutics Accelerator
Trial Phase: Phase 2
Institution: University of Oxford
Trade Name(generic name): ['COVI-GUARD (STI-1499)']
Spnosor: Sorrento Therapeutics
Trial Phase: Phase 1
Institution: Sorrento Therapeutics
Trade Name(generic name): ['PB1046']
Spnosor: PhaseBio
Trial Phase: Phase 2
Institution: PhaseBio
Trade Name(generic name): ['PF-00835321 (PF-07304814)']
Spnosor: Pfizer
Trial Phase: Phase 1b
Institution: Pfizer
Trade Name(generic name): ['Eliquis (Apixaban)']
Spnosor: Operation Warp Speed
Trial Phase: Phase 3
Institution: NHLBI
Trade Name(generic name): ['Takhzyro (lanadelumab)']
Spnosor: Takeda (Shire)
Trial Phase: Phase 1b
Institution: Takeda (Shire)
Trade Name(generic name): ['Hydrocortisone']
Spnosor: Various
Trial Phase: Phase 3
Institution: Various
Trade Name(generic name): ['Ilaris (canakinumab)']
Spnosor: Novartis
Trial Phase: Phase 3
Institution: Novartis
Trade Name(generic name): ['BLD-2660']
Spnosor: Blade Therapeutics
Trial Phase: Phase 2
Institution: Blade Therapeutics
Trade Name(generic name): ['Rhu-pGSN (gelsolin)']
Spnosor: BioAegis Therapeutics
Trial Phase: Phase 2
Institution: BioAegis Therapeutics
Trade Name(generic name): ['TXA127']
Spnosor: Columbia University Irving Medical Center
Trial Phase: Phase 2
Institution: Constant Therapeutics
Trade Name(generic name): ['LAM-002A (apilimod dimesylate)']
Spnosor: AI Therapeutics, Inc., Yale University
Trial Phase: Phase 2
Institution: AI Therapeutics, Inc.
Trade Name(generic name): ['DNL758 (SAR443122)']
Spnosor: Sanofi
Trial Phase: Phase 1b
Institution: Sanofi, Denali Therapeutics
Trade Name(generic name): ['ABX464']
Spnosor: Abivax
Trial Phase: Phase 2b/3
Institution: Abivax
Trade Name(generic name): ['AdMSCs']
Spnosor: Celltex Therapeutics
Trial Phase: Phase 2
Institution: Celltex Therapeutics
Trade Name(generic name): ['Losmapimod']
Spnosor: Fulcrum Therapeutics
Trial Phase: Phase 3
Institution: Fulcrum Therapeutics
Trade Name(generic name): ['Calquence (acalabrutinib)']
Spnosor: AstraZeneca
Trial Phase: Phase 2
Institution: AstraZeneca
Trade Name(generic name): ['Gimsilumab']
Spnosor: Roivant Sciences
Trial Phase: Phase 2
Institution: Roivant Sciences
Trade Name(generic name): ['Otilimab']
Spnosor: GSK
Trial Phase: Phase 2
Institution: MorphoSys, GSK
Trade Name(generic name): ['Farxiga (dapagliflozin)']
Spnosor: AstraZeneca
Trial Phase: Phase 3
Institution: Bristol-Myers Squibb
Trade Name(generic name): ['Ultomiris (ravulizumab)']
Spnosor: Alexion
Trial Phase: Phase 3
Institution: Alexion